Cardiovascular disease in chronic renal failure: pathophysiologic aspects.
about
Speckle tracking echocardiography detects uremic cardiomyopathy early and predicts cardiovascular mortality in ESRD.Medial vascular calcification revisited: review and perspectivesAssociation of pretransplant serum phosphorus with posttransplant outcomes.Relationship of pharyngeal water content and jugular volume with severity of obstructive sleep apnea in renal failure.Intradialytic versus home-based exercise training in hemodialysis patients: a randomised controlled trial.Predictors of increased left ventricular filling pressure in dialysis patients with preserved left ventricular ejection fractionThe relation between hypoalbuminemia and compliance and intima-media thickness of carotid artery in continuous ambulatory peritoneal dialysis patients.Performance Characteristics of Kidney Injury Molecule-1 In Relation to Creatinine, Urea, and Microalbuminuria in the Diagnosis of Kidney DiseaseCardiac and vascular structure and function parameters do not improve with alternate nightly home hemodialysis: an interventional cohort study.Fibroblast growth factor-23 and cardiac structure and function.Novel markers of left ventricular hypertrophy in uremia.Heart failure in subjects with chronic kidney disease: Best management practices.Dissecting the mechanisms of left ventricular diastolic dysfunction and inflammation in peritoneal dialysis patients.Endogenous cardiotonic steroids in chronic renal failure.The prevalence of vascular calcification in patients with end-stage renal disease on hemodialysis: a cross-sectional observational studyLeft Ventricular Global Longitudinal Strain (GLS) Is a Superior Predictor of All-Cause and Cardiovascular Mortality When Compared to Ejection Fraction in Advanced Chronic Kidney Disease.On-Pump versus Off-pump Myocardial Revascularization in Patients with Renal Insufficiency: Early and Mid-term ResultsLeft ventricular global longitudinal strain is associated with cardiovascular risk factors and arterial stiffness in chronic kidney diseaseDeterminants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials.Monoclonal antibody against marinobufagenin reverses cardiac fibrosis in rats with chronic renal failure.Inflammation and vascular calcification.Effect of frequent or extended hemodialysis on cardiovascular parameters: a meta-analysis.Left ventricular diastolic dysfunction in peritoneal dialysis: a forgotten risk factor.Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices.Diagnosis of left ventricular diastolic dysfunction in the setting of acute changes in loading conditions.Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded, parallel intervention study.Low-dose growth hormone is cardioprotective in uremia.Chronic Kidney Disease, Fluid Overload and Diuretics: A Complicated Triangle.Accumulation of epicardial fat rather than visceral fat is an independent risk factor for left ventricular diastolic dysfunction in patients undergoing peritoneal dialysisAssociation of serum albumin and homocysteine levels and cardio-ankle vascular index in patients with continuous ambulatory peritoneal dialysis.Arrhythmic complication in cardiorenal syndrome.Hypertension, left ventricular hypertrophy and chronic kidney disease.Intensive hemodialysis: normalizing the "unphysiology" of conventional hemodialysis?The Impact of Arteriovenous Fistulae for Hemodialysis on the Cardiovascular System.Emerging Roles of IL-33/ST2 Axis in Renal Diseases.Associations of genetic variants of endothelin with cardiovascular complications in patients with renal failure.Serum alkaline phosphatase levels and left ventricular diastolic dysfunction in patients with advanced chronic kidney disease.Echocardiographic changes in patients with stage 3-5 chronic kidney disease and left ventricular diastolic dysfunction.Heart function disturbances in chronic kidney disease - echocardiographic indices.Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure.
P2860
Q30401905-341EC5CC-81CB-4F1C-B05C-C1A480EB0A11Q30409314-2324987B-7829-470C-8BA7-231A07973032Q30424192-7BC98DA9-AB27-4F9B-9BFA-C3692AE32298Q30576778-A58283B7-0D2D-4FD5-8E8A-98174C017282Q33403922-00E391BC-7D92-4CF8-A0CD-EC1BB2F7E547Q33573162-A45C3EB6-53A0-472B-9994-5AB56D90E4F4Q33599393-AF7AAD1D-89BC-433F-97B1-9093A2FDD694Q33718114-31C350AC-7EAF-4C94-B57F-F0BB4E800064Q34036386-FA5A102E-4A24-44FA-8A2A-0FC235AF729AQ34039877-05323347-C2A7-43E4-AAC8-4D9F39EAD8DBQ34074943-052E62A4-4538-4631-8015-F3E474A1B34DQ34390665-6E9A8D61-6E33-45B4-8DB2-AFF9C58C1BF2Q34722642-A32E3C78-8F24-420F-BF09-BC3E90986215Q35466347-7BC656CE-6709-4EED-A483-0473220D40F0Q35561373-A9E2B1C3-D64B-48EE-A150-43B59442F8A0Q35610795-6C6DB67A-E58F-44C8-A92B-47FB094B2AAAQ35644677-913CB529-0641-4CD1-9E16-1BF3D79AD6C7Q35695693-DBB95D4D-E6D6-46DD-BD00-7DA0A83D9182Q35895880-195C362D-6E3B-45AD-ADB1-994722EAAB0EQ35968905-76BAC43A-F52C-4FB7-AD6A-4752897BF048Q35997682-B6B6E471-66EB-42BA-9BD0-21B4E160E2FFQ36090656-D1B945AB-4889-4522-BD71-21ACCD790962Q36152894-25698B9F-901D-48FD-B5C6-93652C45B643Q36297961-955B6D5E-32F7-4141-825D-CDAC47D50FE4Q36392589-53991081-B6D5-4980-9081-27C932900732Q36809901-EA0A2156-3DFE-43CB-9EEC-D753A1BC136BQ36842446-5B15A33D-51DD-4D96-8451-A0E1D4352633Q37115621-7048C701-679E-4D2D-BEEE-93F2C33A76F5Q37153884-FB7452E1-6E13-46B0-9450-A4DF97EF739CQ37475861-2CBEB784-514F-43F2-ADD9-8C8CAD350C24Q37813471-BAEA7E2D-F67E-4C4F-9328-39A6B3B2398CQ37813472-2D1E30B5-6286-4E86-9F37-A03A740558B2Q37961962-1DEB56EE-319B-4FF2-BC31-5F74DBEA7B42Q38693240-D962684F-AFDA-44E8-969A-C3E8E424F58BQ39226501-DDFAEBBE-4BBA-4056-A6CF-09C2403E92ABQ41522985-9F037FA2-D1F4-4944-8C5A-5466CAD4A1F9Q41859737-B96D18A9-5E13-4C34-B31B-B7B18B5566FAQ41885769-6EDAFE12-EA62-4058-A569-20A875BB4054Q41952419-07618ACD-DA4F-4537-BAAF-DD18972201F9Q41980949-8210B2E3-68B7-4B22-85F4-3D5E04E64B99
P2860
Cardiovascular disease in chronic renal failure: pathophysiologic aspects.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Cardiovascular disease in chronic renal failure: pathophysiologic aspects.
@ast
Cardiovascular disease in chronic renal failure: pathophysiologic aspects.
@en
type
label
Cardiovascular disease in chronic renal failure: pathophysiologic aspects.
@ast
Cardiovascular disease in chronic renal failure: pathophysiologic aspects.
@en
prefLabel
Cardiovascular disease in chronic renal failure: pathophysiologic aspects.
@ast
Cardiovascular disease in chronic renal failure: pathophysiologic aspects.
@en
P1433
P1476
Cardiovascular disease in chronic renal failure: pathophysiologic aspects.
@en
P2093
Gérard M London
P356
10.1046/J.1525-139X.2003.16023.X
P577
2003-03-01T00:00:00Z